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Abstract
Parasitological cure for Chagas disease is considered extremely difficult to achieve because of the lack of effective
chemotherapeutic agents against Trypanosoma cruzi at different stages of infection. There are currently only two drugs
available. These have several limitations and can produce serious side effects. Thus, new chemotherapeutic targets are
much sought after. Among T. cruzi components involved in key processes such as parasite proliferation and host cell
invasion, Ca2+-dependent molecules play an important role. Calcineurin (CaN) is one such molecule. In this study, we cloned
a new isoform of the gene coding for CL strain catalytic subunit CaNA (TcCaNA2) and characterized it molecularly and
functionally. There is one copy of the TcCaNA2 gene per haploid genome. It is constitutively transcribed in all T. cruzi
developmental forms and is localized predominantly in the cytosol. In the parasite, TcCaNA2 is associated with CaNB. The
recombinant protein TcCaNA2 has phosphatase activity that is enhanced by Mn2+/Ni2+. The participation of TcCaNA2 in
target cell invasion by metacyclic trypomastigotes was also demonstrated. Metacyclic forms with reduced TcCaNA2
expression following treatment with morpholino antisense oligonucleotides targeted to TcCaNA2 invaded HeLa cells at a
lower rate than control parasites treated with morpholino sense oligonucleotides. Similarly, the decreased expression of
TcCaNA2 following treatment with antisense morpholino oligonucleotides partially affected the replication of
epimastigotes, although to a lesser extent than the decrease in expression following treatment with calcineurin inhibitors.
Our findings suggest that the calcineurin activities of TcCaNA2/CaNB and TcCaNA/CaNB, which have distinct cellular
localizations (the cytoplasm and the nucleus, respectively), may play a critical role at different stages of T. cruzi
development, the former in host cell invasion and the latter in parasite multiplication.
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Introduction
Chagas disease, whose etiological agent is Trypanosoma cruzi, is a
neglected tropical parasitic infection. An estimated 10 million
people are infected worldwide, predominantly in Latin America,
where it is endemic, and more than 25 million people are at risk of
acquiring the disease [1]. The two chemical therapeutic agents
used to treat the disease (Nifurtimox and Benznidazole) may cause
side effects, and parasitological cure is not achieved in all cases
[2,3]. Identification of key factors in the life cycle of the parasite
that could be targets for new chemotherapeutic strategies is
therefore very important.
In the life cycle of T. cruzi, epimastigote forms replicate in the
insect vector and then differentiate into metacyclic trypomastigotes,
which are infective to the mammalian host. Cell invasion by
metacyclic forms is crucial for the establishment of T. cruzi infection.
Inside host cells, the parasite replicates as amastigotes, which
subsequently transform into trypomastigotes. When the host cell
ruptures, these are released to the circulation. There is evidence that
Ca2+-dependent events are implicated in various processes that are
critical for the maintenance of the T. cruzi life cycle. It has been
shown that the Ca2+ chelator EGTA decreases epimastigote
multiplication and that intracellular Ca2+-concentration increases
about six-fold during differentiation of epimastigotes into metacyclic
trypomastigotes, an event that is blocked by calmodulin inhibitors
[4]. Induction of Ca2+ signaling in insect-stage and bloodstream
trypomastigotes is an important requirement for target cell invasion
[5,6]. Further, it has been suggested that the Ca2+ signal induced in
metacyclic forms is associated with the activation of a protein
tyrosine kinase [7]. Protein kinases and phosphatases, which control
the phosphorylation state of tyrosine, serine and threonine residues,
play a pivotal role in cell signal regulation and integration in all
living organisms, including trypanosomatids [8,9]. T. cruzi protein
phosphatase 2A (PP2A), for instance, has been implicated in the
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transformation of trypomastigotes into amastigotes [10]. In this
scenario, a homolog of mammalian calcineurin has emerged as an
important factor for T. cruzi infection.
In cells of different tissues, the Ca2+-dependent phosphatase
calcineurin, also known as PP2B or CaN, is involved in a number of
different signaling pathways. An evolutionarily conserved protein in
all eukaryotes, it appears to be ubiquitously expressed [11,12,13]. It
is heterodimeric and consists of calcineurin A (CaNA), the catalytic
subunit, and calcineurin B (CaNB), the Ca2+-binding subunit [12].
In T. cruzi clone CL Brener, Moreno et al. [14] identified a protein
homologous to CaNA, which is predominantly localized in the
nucleus and, unlike its mammalian counterpart, has a catalytic
domain and a CaNB-binding domain but lacks the binding domain
to calmodulin and the autoinhibitory domain (AID). A protein
phosphatase with the same characteristics was also detected in T.
cruzi CL and G strains, and the sequence of its regulatory subunit
(TcCaNB) was determined, revealing the presence of three Ca2+-
binding domains, known as EF-hand motifs [15]. Treatment of CL
strain metacyclic or tissue culture trypomastigotes with CaN
inhibitors, such as cyclosporin and cypermethrin, or with antisense
phosphorothioate oligonucleotides directed to TcCaNB was shown
to inhibit parasite entry into host cells [15]. Whether TcCaN plays
other biological functions essential for T. cruzi development had not
been investigated prior to the present study. We addressed this
question and found that TcCaN is also involved in parasite
multiplication. In addition, we identified a new isoform of TcCaNA,
TcCaNA2 (HM854297), which is localized in the cytoplasm and is
implicated in a number of important events, including trypomas-
tigote entry into target cells.
Materials and Methods
Ethics statement
All animal handling protocols were performed according to the
‘‘Guide for the Care and Use of Laboratory Animals’’ from the
National Institutes of Health, USA [16] and approved by the
Institutional Ethics Committee at the Faculty of Health Sciences,
University of Antofagasta, Chile (CEIC REV/200) under
FONDECYT-Chile grant number 1051045.
Parasite and cell invasion assay
T. cruzi CL strain [17], used throughout this study, was
maintained cyclically in Balb/c mice and in axenic liver infusion
tryptose (LIT) medium containing 5.0 g liver infusion, 5.0 g
tryptose, 4.0 g NaCl, 0.4 g KCl, 8.0 g Na2HPO4, 2.0 g glucose
and 10.0 mg hemin per liter and supplemented with 5% fetal
bovine serum. Epimastigote forms were grown at 28uC in LIT
medium, and Grace’s medium was used to obtain cultures enriched
in metacyclic trypomastigote forms, which were purified by
chromatography using a diethylaminoethyl (DEAE) cellulose
column (Sigma Chemical Co), as described by Teixeira et al. [18].
Cell invasion assays were performed as described by Ramirez et al.
[19]. Briefly, 26105 HeLa cells were cultured in 4-well Lab-Tek
Chamber Slides (Nunc, Thermo Scientific). After adhesion and
growth at 37uC in a humidified 5% CO2 atmosphere, the cells were
incubated with 16106 metacyclic trypomastigotes (MT) previously
treated or not with different calcineurin inhibitors. After 3 h
incubation, the cells were washed with PBS and fixed with methanol
followed by Giemsa staining. The number of intracellular parasites
was counted in 100 cells. Assays were conducted in triplicate. The
viability of MT was evaluated by Trypan blue exclusion and by
parasite migration assay through gastric mucin layer. Briefly,
polycarbonate transwell filters (3 mm pores, 6.5 mm diameter,
Costar) were coated with 50 mL of a preparation containing 10 mg/
ml gastric mucin. T. cruzi metacyclic trypomastigotes, in 600 mL
PBS were added to the bottom of 24-well plates (16107 parasites/
well) and incubated for 1 h at 37uC. Thereafter, the mucin-coated
transwell filters were placed onto parasite-containing wells, and
100 mL PBS were added to the filter chamber. After 1 h of
incubation at 37uC, 10 mL were collected from the filter chamber
for determination of parasite number and the volume in this
chamber was corrected by adding 10 mL PBS [20].
Parasite proliferation inhibition assay
Epimastigotes maintained in LIT medium were used for
proliferation assays. Parasites in growth phase were incubated
with different concentrations of calcineurin inhibitor cyclosporin A
(CsA). Untreated or treated parasites with ethanol were used as
controls. Assays were performed with three different cultures, each
containing 56105 epimastigotes per sample in a volume of 1 mL
of LIT medium. Parasite cultures were analyzed daily for one
week by taking samples to measure the number of parasites using a
Neubauer hemocytometer, and the viability of epimastigotes was
determined under light microscopy using Trypan blue exclusion
and CFDA-SE assays [21]. Results were expressed as mean 6
standard error of three independent experiments. Similarly,
epimastigotes were incubated with different concentrations of
calcineurin inhibitors [CsA, tacrolimus (FK-506), INCA-6 and
kaempferol (Kmp)] at 0, 10, 20 and 40 mM. Crystal violet was used
as a positive control because of its trypanocidal effect. Assays were
performed in triplicate in 96-well microplates containing 56105
epimastigotes per well in 200 mL of LIT medium. After 72 h
incubation, the number of parasites was counted as described
above. Untreated epimastigote cultures were used as a negative
control. Results were expressed as a percentage of proliferation
(number of cells) in the control group.
Isolation of nucleic acids, Southern and Northern blot
hybridizations and separation of chromosomal bands
Isolation of genomic DNA and total RNA from T. cruzi CL
strain, Southern and Northern blot hybridizations and separation
of chromosomal bands by pulsed-field gel electrophoresis were
performed as described previously [10].
Author Summary
Chagas disease is a neglected tropical parasitic infection.
An estimated 10 million people are infected worldwide,
and more than 25 million people are at risk of acquiring
the disease. The therapeutic agents used to treat the
disease may not be effective in all cases and also produce
considerable side effects. Therefore, it is important to
identify the key factors in the life cycle of the parasite that
could be targets for new chemotherapeutic strategies. This
paper provides evidence that a new cytoplasmic catalytic
subunit of T. cruzi calcineurin (TcCaNA2) may play a critical
role in host cell invasion by metacyclic trypomastigotes.
Metacyclic forms with reduced TcCaNA2 expression
following treatment with antisense morpholino oligonu-
cleotides had significantly decreased capacity to invade
HeLa cells. Epimastigote proliferation was inhibited to
some extent by treatment with an antisense morpholino
oligonucleotide targeted to TcCaNA2, but to a lesser
degree than by calcineurin inhibitors (CsA, FK506 and
INCA-6). The structural differences between TcCaNA2 and
its human ortholog CaNA were analyzed to determine the
potential of this newly identified calcineurin subunit as a
chemotherapeutic target.
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Cloning of T. cruzi CaNA2 and CaNB genes
To clone the CaNA2 gene of T. cruzi CL strain, sense and
antisense primers were designed based on the sequence of the
genome of CL Brener clone available in GenBank (http://www.
ncbi.nlm.nih.gov) under accession number XM_816360.1. Sense
primer 59-ATG TTG TCT ACA TCA GAT TCT-39 and
antisense primer 59-TCA TTT GCA TCC CTT ATT TAG-39
were used. After amplification of the TcCaNA2 gene by RT-PCR
with 1–20 ng of T. cruzi cDNA synthesized using poly A+ mRNA
(using oligo dT) obtained from epimastigotes, PCR products were
analyzed by agarose gel electrophoresis. The amplification product
was cloned in the vector pCR 2.1-TOPO (TOPO Cloning Vector
Kit for sequencing, Invitrogen by Life Technologies) according to
the manufacturer’s instructions. The CaNB gene was amplified by
RT-PCR using a pair of primers: sense 59-CGG AAT TCA TGG
GCG AGG GGG T-39 and antisense 59-CGG AAT TCC TAA
ATG GAG AGG C-39, which were based on a cDNA sequence
from the CL strain (accession number AY570505). A cloning
protocol similar to that described for the TcCaNA2 gene was used.
Sequences were analyzed using DNASTAR and GeneDoc
software and National Center for Biotechnology Information
(NCBI) programs (http://www.ncbi.nlm.nih.gov).
Expression and purification of recombinant proteins
TcCaNA2 and TcCaNB
The coding sequences of TcCaNA2 and TcCaNB genes were
subcloned into the expression vector pGEX-1lT (GE Healthcare)
in-frame with glutathione S-transferase (GST) gene. After
sequencing the construct to check that the open reading frame
was in the correct orientation, expression of the recombinant
protein was induced in E. coli BL21 (DE3) after addition of 1 mM
isopropyl thio-b-D-galactoside (IPTG). The recombinant protein
was purified by the cleared lysate method using gluthathione-
Sepharose 4B (Amersham Biosciences). After washing with PBS
pH 7.3, the proteins of interest were eluted with 200 mM Tris-
HCl pH 8.0, 40 mM reduced glutathione, 150 mM NaCl, 5 mM
DTT and 0.1% Triton X-100. Analysis of the purified protein was
carried out by SDS-PAGE on 10% gels stained with Coomassie
blue. Additionally, the coding sequence of TcCaNA2 was cloned
in-frame into the expression vector pET-SUMO (Champion pET
Expression System, Invitrogen by Life Technologies). The
recombinant protein was expressed in E. coli BL21 (DE3) after
induction with IPTG, and the protein (66His-SUMO-TcCaNA2)
was purified from cleared lysates by affinity chromatography on
Ni-NTA agarose (Invitrogen by Life Technologies). After elution
in the presence of imidazole (SIGMA), the purity of the protein
was determined as above.
Determination of enzymatic activity of TcCaN and
TcCaNA2
To measure TcCaN activity, parasites were washed three times
with TBS (150 mM NaCl, 20 mM Tris, pH 7.2) and then lysed in
lysis buffer (50 mM Tris pH 7.5, 1 mM DTT, 100 mM EDTA,
100 mM EGTA, 0.2% NP-40) and centrifuged at 100,0006 g for
45 min at 4uC. The high-speed post-lysis supernatants were used
to evaluate calcineurin-type phosphatase activity with a Calci-
neurin Cellular Activity Assay Kit, Colorimetric (Calbiochem,
USA), according to the manufacturer’s instructions. To determine
the phosphatase activity of TcCaNA2, the assay was performed
using 1 mg of the recombinant protein in the presence of one of the
following metal ions at 1 mM: CaCl2, MgCl2, MnCl2 or NiCl2.
The recombinant TcCaNA2 was incubated for 15 min at 30uC
with 80 mM p-nitrophenyl phosphate (p-NPP) (Calbiochem, USA)
as substrate. The reaction was stopped by adding 950 mL of 1 M
NaOH, and enzyme activity was measured by the change in
absorbance at 405 nm, as described by Sagoo et al. [22]. Similarly,
the activity of 1 mg of TcCaNA2 combined with 1 mg of TcCaNB
was measured in the presence of 1 mM of MnCl2 with or without
EGTA.
Generation and purification of antibodies
Two protocols were developed to generate antibodies. First,
BALB/c mice and/or New Zealand white rabbits (after obtaining
pre-immune serum) were immunized with GST-TcCaNA2 and
GST-TcCaNB recombinant proteins. Each animal received 4
doses of 10 mg antigen plus 0.5 mg Al(OH)3 as adjuvant at 7-day
intervals. After the last immunization dose, blood was obtained by
cardiac puncture. The polyclonal antiserum was divided into
aliquots and stored at 220uC in the presence of 0.1% sodium
azide as preservative. Monospecific polyclonal antibodies against
the TcCaNA2 isoform were raised in New Zealand white rabbits
by immunization with the synthetic peptides 246–264
(CGSKSDYYTPSAGPSYGSKP-amide) and 206–224 (Ac-IKLN-
HIDLIHRFRE PPSRGC-amide) conjugated to KLH (Keyhole
limpet hemocyanin) or ovalbumin using MBS (m-Maleimidoben-
zoyl-N-hydroxysuccinimide ester). The monospecific antibodies
were purified by affinity chromatography using the peptide 246–
264, which is only present in the TcCaNA2 isoform, as ligand.
Far-Western blot analysis
To evaluate the interaction between TcCaNA2 and TcCaNB, a
Far-Western blotting was performed as described by Wu et al. [23]
using the recombinant proteins TcCaNB (tagged with GST) and
TcCaNA2 (tagged with 66His). BSA and the unrelated fusion
protein 66His-SUMO-CAT were used as negative controls. One
microgram each of BSA, CAT and 66His-SUMO-TcCaNA2
(target protein) were resolved in 10% SDS-PAGE and transferred
onto PVDF membranes, which were then incubated with
decreasing concentrations of guanidine-HCl (6, 3, 1, 0.1, and
0 M) to denature and renature the target protein. The membrane
was then blocked with PBS containing 0.5% Tween 20 and 5%
skim milk and incubated with 10 mg of the bait protein GST-
TcCaNB. A rabbit polyclonal antibody directed to GST-TcCaNB
and an anti-rabbit IgG antibody conjugated to horseradish
peroxidase (Sigma-Aldrich) were used to detect TcCaNA2-
TcCaNB interaction. The immunocomplexes were revealed using
diaminobenzidine (DAB) as substrate.
Western blot for detection of TcCaNA2 in parasite
extracts
Epimastigotes (16107) were lysed in Laemmli buffer (62.5 mM
Tris-HCl pH 6.8, 25% glycerol, 2% SDS, 0.01% bromophenol
blue) and exposed to different concentrations of urea (0, 2, 4 and
6 M) overnight at 4uC to stabilize the solutions, which were then
separated on 10% SDS-PAGE gels, electrotransferred to a PVDF
membrane (Amersham Hybond-P) and visualized by Western blot.
Antisense oligonucleotides (AS-ONs, morpholino type)
directed to TcCaNA2
The antisense oligonucleotide (AS-ON) used was 59- GAG AAT
ATG CTG TAG ACA ACA TTA T-39, and the AS-ON control
was a standard unrelated oligonucleotide: 59-CCT CTT ACC
TCA GTT ACA ATT ATT-39. The assays were performed in the
presence of antisense oligonucleotides directed to TcCaNA2 (third
generation morpholino, Gene Tools, LLC), and the effects were
evaluated as described above for the assays used to detect
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inhibition of cell proliferation and invasion. Each AS-ON was
added at a concentration of 10 mM with 6 mM of Endo-Porter,
according to the Gene Tools ‘‘Endo-Porter delivery of morpholino
oligos’’ protocol.
Determination of the subcellular distribution of TcCaNA2
Epimastigotes in exponential growth phase (CL strain) were
centrifuged at 6,0006 g for 5 min, washed twice in PBS pH 7.2
and then resuspended at 26106 parasites/mL. Parasites were
decanted on poly-L-lysine-treated cover slips and fixed in PBS
containing 4% paraformaldehyde. Next they were permeabilized
with PBS-0.5% Triton X-100 for 5 min at room temperature and
blocked with a solution of 2% glycine, 2% BSA, 5% FCS and
50 mM NH4Cl in PBS pH 7.2. The cover slips were then
incubated with the primary antibodies, washed three times for
5 min in PBS pH 7.2 and incubated with the secondary antibodies
(anti-mouse Alexa Fluor 488 and anti-rabbit Alexa Fluor 568).
The samples were visualized with a reflected light microscope
(Carl Zeiss, model Axiovert 10), photographed and analyzed using
QCapture Pro 6.
Statistical analysis
Statistical analysis was carried out with GraphPad Prism v. 5.0
(GraphPad Software, Inc., San Diego, CA). Values of p,0.05
were considered significant.
Results
Effect of CaN inhibitors on T. cruzi proliferation
It has previously been shown that the treatment of CL strain
metacyclic trypomastigotes or tissue culture-derived trypomasti-
gotes with calcineurin inhibitors CsA or cypermethrin resulted in
strong inhibition (62–64%) of parasite entry into HeLa cells [15].
To determine the role of TcCaN in parasite growth, epimastigotes
were incubated in the absence or presence of varying concentra-
tions of the calcineurin inhibitor CsA. Starting on the day CsA was
added, parasite density was measured daily for one week, and it
was observed that parasite growth was inhibited by CsA. At
20 mM and 40 mM, CsA inhibited parasite growth completely
whereas at 10 mM inhibition was partial (Figure 1A). Epimasti-
gotes treated with CsA for 24 h remained viable and were
indistinguishable from the control untreated parasites (morphology
and motility), although their growth was impaired. Loss of viability
was observed when epimastigotes were treated with CsA for 48 h
or longer (data not shown). Other calcineurin inhibitors, such as
FK-506 and INCA-6, were also tested, with similar results
(Figure 1B). Among the inhibitors tested, CsA and FK-506 were
more effective than INCA-6 to inhibit parasite proliferation. No
inhibition was observed after treatment with kaempferol
(Figure 1B). These data indicate that TcCaN plays an important
role at different stages in T. cruzi development.
Isolation and characterization of the gene encoding a
new catalytic subunit of T. cruzi CaN (TcCaNA2)
The nucleotide sequence corresponding to a gene coding for the
catalytic subunit of the CL strain CaN, which is distinct from that
previously reported [15] and was therefore called TcCaNA2, was
obtained by RT-PCR amplification using primers based on a
genomic sequence of clone CL Brener and deposited in GenBank
under accession number HM854297. In silico analysis using
BLASTp showed 44% identity between TcCaNA2 and CL strain
TcCaNA (accession number EU195113), described by Araya et al.
[15], and between TcCaNA2 and the catalytic subunit A (CnA-like:
accession number AJ878872), described by Moreno et al. [14] for
CL Brener clone.
The TcCaNA2 nucleotide sequence showed an open reading
frame (ORF) of 1179 bp, which codes for a polypeptide of 392
amino acids with an estimated molecular mass of 44.5 kDa. The
deduced amino acid sequence of TcCaNA2 possesses the domain
that interacts with CaNB, but the calmodulin-binding domain and
AID are absent (Figure 2A). The conserved GDXHG,
GDXVDRG and GNHE (phosphoesterase) motifs, which are
characteristic of serine-threonine protein phosphatases, are present
(Figure 2A). A strong homology between TcCaNA2 and CaNA
from other species was found: 44% identity with Homo sapiens and
45% with Drosophila melanogaster and Neurospora crassa. Among
trypanosomatids, TcCaNA2 showed 46% and 67% identity with
CaNA from Leishmania major and Trypanosoma brucei, respectively.
The neighbor-joining cladogram revealed twomajor clusters, one
of which contains CaNA from three trypanosomatids: T. brucei
TREU927 (XP_822888.1), Leishmania infantum (XP_001469789.1)
and T. cruzi (TcCaNA2-CL, HM854297). This shows the ancestral
relation of these organisms and the closer relationship between the
two Trypanosoma species (Figure 2B); the CaNA2 gene of T. cruzi is
the most conserved among the species analyzed. The second cluster
included Schizosaccharomyces pombe 972 h- (NP_596178.1), D. melano-
gaster (Q27889.2) and the alpha isoform of H. sapiens (EAX06123.1),
showing an evolutionary variation among species (Figure 2B).
Genomic organization and transcription of TcCaNA2
A BLASTn search [http://www.genedb.org; Gish, W. (1996–
2006); http://blast.wustl.edu] retrieved the 21178 bp contig 8328,
which contains one copy of the TcCaNA2 gene; a query in the
kinetoplastid genome database (2012 The EuPathDB Project
Team; http://tritrypdb.org/tritrypdb/) showed that the
TcCaNA2 gene is located on chromosome TcChr37P, which
belongs to the non-Esmeraldo haplotype of CL Brener clone.
However, no sequence similarity was found within chromosome
TcChr37S from Esmeraldo haplotype (data not shown).
Southern blot analysis of CL strain genomic DNA showed a
simple pattern of hybridization with a probe derived from
TcCaNA2 gene, with two internal BamHI restriction sites
(Figure 3A). The same probe revealed only one chromosomal
band (chromosomal band XX,3.27 Mb) in clone CL-Brener and
CL strain chromosomes resolved in pulsed field gel electrophoresis
(Figure 3B). This hybridization profile suggests that a single copy
of TcCaNA2 gene is present, although the presence of two co-
migrating chromosomal bands cannot be ruled out. Northern blot
hybridizations showed a transcript of approximately 1.5 kb in all
developmental stages of the parasite (Figure 3C), indicating that
the transcription of TcCaNA2 is constitutive. Densitometric
analysis on the same autoradiogram hybridized with a tubulin-
derived probe confirmed equal loading of the samples (data not
shown). Similarly, using a pair of primers flanking the ORF of the
TcCaNA2 gene, an RT-PCR on cDNA freshly synthesized from
parasite mRNA revealed amplification in all developmental forms
(Figure 3D), confirming what was observed in the Northern blot
(Figure 3C). Correspondingly, TcCaNA2 protein was also
detected in all developmental stages (TCT, MT, A and E), being
the protein levels slightly greater in MT and TCT, as demon-
strated by immunoblotting (Figure 3D).
Enzymatic activity of TcCaNA2 and the effect of metal
ions
The activity of the purified recombinant TcCaNA2 was
determined after its purity and specific recognition by polyclonal
monospecific anti-TcCaN2 antibody had been confirmed.
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Recombinant TcCaNA2 was incubated in the absence or presence
of 1 mM CaCl2, MgCl2, MnCl2 or NiCl2, and the reaction using
p-NPP as substrate proceeded for 15 min at 30uC. Absorbance
reading at 405 nm revealed higher TcCaNA2 activity in the
presence of Mn2+ or Ni2+, indicating that these metal ions are
more effective cofactors than Ca2+ or Mg2+ (Figure 4A). Our data
showing that the recombinant TcCaNA2 is activated by Mn2+/
Ni2+ (Figure 4A) are compatible with the report suggesting that
enzyme activation by Mn2+/Ni2+ is mainly mediated via the
catalytic domain, if it is assumed that the non-catalytic domains of
subunit A negatively regulate the activity of calcineurin by acting
as intra-molecular inhibitors [24]. As TcCaNA2 interacts with
TcCaNB in vivo, the activity of TcCaNA2 combined with TcCaNB
was measured, by adding 1 mg of each protein recombinant.
TcCaNA2 activity did not depend on its association with TcCaNB
(Figure 4B). Taking into account that the specific activity is
expressed as nmol per min per mg protein, the reduced activity of
TcCaNA2, when combined with TcCaNB, is only apparent and is
due to the presence of 2 mg protein. Activity of TcCaNA2/
TcCaNB was significantly inhibited by EGTA (Figure 4B).
Interaction between recombinant TcCaNA2 and TcCaNB
proteins and the effect of urea on dissociation of native
TcCaNA2/TcCaNB
To confirm the molecular interaction between TcCaNA2 and
TcCaNB, we performed a Far-Western blot assay as described by
Wu et al. [23]. The recombinant proteins GST-TcCaNB and
66His-SUMO-TcCaNA2 were used as bait and target, respec-
tively. As negative controls, BSA and the unrelated fusion protein
66His-SUMO-CAT were used. Binding of GST-TcCaNB to
66His-SUMO-TcCaNA2 was shown using the mouse polyclonal
anti-TcCaNB antibody and anti-IgG tagged with horseradish
peroxidase. As shown in Figure 5A, TcCaNB interacts with
TcCaNA. We ascertained that anti-TcCaNB antibody specifically
reacts with TcCaNB and does not recognize 66His-SUMO-
TcCaNA2 (Figure 5B). In addition, to show that native TcCaNA2
and TcCaNB are associated in the parasites, we performed an
assay to detect the dissociation of the two subunits. Total extracts
from epimastigotes (16107) were exposed to different concentra-
tions of urea at 4uC, subjected to SDS-PAGE and electroblotted
onto PVDF, and TcCaNA2 was revealed using anti-TcCaNA2
antibody and peroxidase-conjugated IgG, followed by ECL. In the
absence of urea, a band of approximately 63.5 kDa was detected
(Figure 5C) that is compatible with the size of TcCaNA2/
TcCaNB assuming that the molecular mass of TcCaNA2 is
44.5 kDa and that of TcCaNB 19 kDa, as determined by Western
blot using antibodies specific to these subunits (Figure 5D). After
treatment of parasite extracts with urea, there was a change in this
profile. A component of about 45 kDa appeared as a weak band in
the sample treated with 2 M of urea, had its intensity increased
with 4 M of urea and was the sole band detected by anti-
TcCaNA2 antibody (Figure 5C). We inferred from this observa-
tion that TcCaNA2 and TcCaNB are closely associated in T. cruzi.
Cytosolic localization of TcCaNA2 in T. cruzi and CaN
activity in high-speed cytosolic extracts
It has been shown by Moreno et al. [14] in clone CL Brener that
CaNA is present predominantly in the parasite nucleus. We
examined the cellular distribution of TcCaNA2 in epimastigotes of
CL strain. To this end, parasites were fixed in paraformaldehyde,
permeabilized with 0.5% Triton X-100, incubated with specific
antibodies to TcCaNA2 and then processed for immunofluorescence.
Figure 6A shows that TcCaNA2 has a predominantly cytoplasmic
localization, with a diffuse and/or slightly speckled pattern.
To show that CaN activity was detectable in the parasite
cytosol, we performed in vitro assays with high-speed cytosolic
Figure 1. Effect of calcineurin inhibitors on T. cruzi proliferation. A) Epimastigotes were incubated with different concentrations of CsA (10,
20 and 40 mM). Untreated parasites or parasites treated with ethanol were used as a control. Assays were performed in three different cultures, each
containing 56105 epimastigotes per sample in 1 mL of LIT medium supplemented with 10% FBS. Cultures were monitored daily for one week to
determine parasite density. B) T. cruzi epimastigotes were maintained for 72 hours in LIT medium supplemented with 10% FBS in the absence
(control) or with different concentrations (5, 10, 20 and 40 mM) of the following calcineurin inhibitors: CsA, FK-506, INCA-6 and kaempferol. Cell
proliferation was calculated as a percentage of the number of parasites in the control group. Results are expressed as mean6 standard error of three
independent experiments performed in triplicate.
doi:10.1371/journal.pntd.0002676.g001
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Figure 2. Comparison of TcCaNA2 amino acid sequence with catalytic subunits from different species. A) Alignment of T. cruzi CL strain
TcCaNA2 (HM854297) with CaNA from Trypanosoma brucei TREU927 (TbXP_822888.1), Leishmania infantum (LiXP_001469789.1), Schizosaccharomyces
pombe 972 h (SpNP_596178.1), Drosophila melanogaster (DmQ27889.2) and the alpha isoform of Homo sapiens (HsEAX06123.1). Genbank accession
numbers are in parentheses. Conserved residues are in black (100% conservation), dark gray (.75% conservation) and light gray (.50%
conservation); no shading denotes residues with,50% conservation. The peptide sequence 243-VSGGSGSDYYTPSAGPSYGS-262 is marked with a line
within the box. B) Phylogenetic tree inferred from the amino acid alignments of TcCaNA2-CL with other CaNAs. Phylogenetic analysis was performed
with MEGA4 software [71]. Evolutionary history was analyzed using the Neighbor-Joining method [72] with 1000 bootstrap replicates [73].
Evolutionary distances were calculated using the Poisson correction method [74] and are in units of number of amino acid substitutions.
doi:10.1371/journal.pntd.0002676.g002
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extracts from metacyclic trypomastigotes and epimastigotes
depleted of phosphates and nucleotides. The cytosolic extracts
were assayed in the presence or absence of EGTA to determine
the contribution of calcium-dependent activity (CaN/PP2B) to
total phosphatase activity (PP1+PP2A+PP2B+PP2C). In both
parasite forms CaN activity was detected in the cytosol, amounting
to 34.6% and 40.0% of the total phosphatase activity in metacyclic
forms and epimastigotes, respectively. Figure 6B shows the result
on CaN activity in cytosol of epimastigotes.
Inhibition of T. cruzi proliferation and host cell invasion
by antisense TcCaNA2 oligonucleotides
We had previously found that CaN is implicated in host cell
invasion [15]. To determine if TcCaNA2 was involved in that
Figure 3. Genomic organization and transcription of T. cruzi CaNA2 gene. A) Southern blot hybridization. CL strain genomic DNA was
digested with the indicated restriction enzymes, electrophoresed in agarose gel (1), transferred to Hybond-N membrane and hybridized to the 32P-
labeled TcCaNA2 gene probe (2). Size markers are indicated in kilobases (kb). B) Chromoblot hybridization. Chromosomal bands of epimastigotes
from clone CL-Brener (CLB) and CL strain (CL) were separated by PFGE, stained with ethidium bromide (1), transferred to Hybond-N membrane and
hybridized with the same probe described above (2). Size markers are indicated in megabase pair (Mbp). C) Northern blot hybridization. Total RNA
(12 mg) extracted from different developmental forms of T. cruzi CL strain (TCT: tissue culture trypomastigotes, MT: metacyclic trypomastigotes, A:
amastigotes, E: epimastigotes) was subjected to formaldehyde-agarose gel electrophoresis, stained with ethidium bromide (1), transferred to
Hybond-N membrane and hybridized with the same probe described above (2). M, molecular size markers, are indicated in kilobases (kb). D)
Amplification of TcCaNA2 gene by RT-PCR (upper) and immunoblotting of TcCaNA2 protein expression (lower) in different developmental forms of T.
cruzi. M, molecular size markers (kb). (+): positive control, corresponds to plasmid pCR 2.1-TOPO with TcCaNA2.
doi:10.1371/journal.pntd.0002676.g003
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Figure 4. Effect of metal ions on the phosphatase activity of rTcCaNA2 and TcCaNA2/TcCaNB. A) Catalytic activity was evaluated in the
presence of the divalent cations at 1 mM, using 80 mM p-NPP as substrate and 1 mg rTcCaNA2. All data are presented as means 6 standard error of
the mean (SEM) of triplicates. Statistical significance was determined by Tukey’s Multiple Comparison Test (p,0.05). **p= 0.0015 and *p,0.05 in
relation to the activity without metal ions. The results are representative of two independent experiments performed in triplicate. B) Catalytic activity
of TcCaNA2 was evaluated as in A in the presence of rTcCaNB and/or EGTA. Statistical significance was determined by Tukey’s Multiple Comparison
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Test (p,0.05). *p,0.05 in relation to the activity with only rTcCaNA2 and **p,0.05 in relation to activity of rTcCaNA2/rTcCaNB heterodimer. The
results are representative of two independent experiments performed in triplicate.
doi:10.1371/journal.pntd.0002676.g004
Figure 5. Interaction between TcCaNA2 and TcCaNB and the effect of urea on the dissociation of native TcCaNA2/TcCaNB. A) Far-
Western blotting was used to detect interaction between recombinant TcCaNA2 and TcCaNB proteins. BSA (66.5 kDa) and the recombinant proteins
66His-SUMO-CAT (39.0 kDa) and 66His-SUMO-TcCaNA2 (55.7 kDa) were subjected to SDS-PAGE and electroblotted onto a PVDF membrane. Proteins
were denatured and renatured and subsequently incubated with purified GST-TcCaNB (45.0 kDa) protein. The arrow indicates the position of 66His-
SUMO-TcCaNA2 (55.7 kDa). B) GST-TcCaNB and 66His-SUMO-TcCaNA2 proteins were subjected to SDS-PAGE and electroblotted onto a PVDF
membrane, which was then incubated with the anti-GST-TcCaNB antibodies to ascertain specific recognition of TcCaNB. The arrow indicates the
position of GST-TcCaNB. C) Total protein extracts from epimastigotes (16107) were treated at 4uC with urea at the indicated concentrations,
subjected to SDS-PAGE and electroblotted onto PVDF membrane, which was reacted with anti-TcCaNA2 monospecific polyclonal antibody. D)
Immunoblotting of total protein extracts of T. cruzi epimastigotes treated with 4 M urea using monospecific polyclonal antisera directed toward
TcCaNA2 (rabbit) and TcCaNB (mouse).
doi:10.1371/journal.pntd.0002676.g005
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process, we performed an inhibition assay using third-generation
AS-ONs (morpholino oligonucleotides) associated with the Endo-
Porter carrier (Gene Tools). This strategy has been used
successfully in many studies [15,25–28]. Metacyclic trypomasti-
gotes (46107) were incubated with 10 mM of sense or antisense
morpholino oligonucleotides directed to TcCaNA2 for 24 h and
then incubated with HeLa cells for 3 h to analyze their invasive
capacity. After washing with PBS, cells were fixed and stained with
Giemsa, and the number of intracellular parasites was counted.
Parasites treated with antisense TcCaNA2 oligonucleotides
showed a significant decrease in invasivity (70%) while no
inhibitory effect of sense oligonucleotides on parasite infectivity
was observed (Figure 7A). The decrease in TcCaNA2 expression
in parasites treated with antisense oligonucleotide but not with
their sense counterparts was ascertained by immunoblotting using
anti-TcCaNA2 antibodies, 45% according to densitometric
analysis (Figure 7A, lower panel).
To demonstrate that the reduced cell invasion capacity of
metacyclic forms treated with antisense oligonucleotides was not
due to diminished parasite viability, we performed an additional
assay that consisted of determining the parasite’s capacity to migrate
through a polycarbonate transwell filter coated with gastric mucin.
Viable parasites cross the gastric mucin-coated filter propelled by
ATP-driven flagellar movement [20]. Metacyclic forms were
treated as above with 10 mM of sense or antisense morpholino
oligonucleotides directed to TcCaNA2 with Endo-Porter or with
the carrier alone. After 16 h at 28uC, the parasites were used in a
parasite migration assay through a mucin layer and in a cell invasion
assay. Gastric mucin-coated transwell filters were placed onto the
wells of 24-well plates containing metacyclic forms in PBS (107/
mL), and 100 mL PBS were added to the filter chamber. After 1 h at
37uC, 10 mL were collected from the filter chamber to determine
the number of parasites. We found that a comparable number of
parasites had crossed the gastric mucin-coated filter regardless of
Figure 6. Cellular localization of T. cruzi TcCaNA2. A) Epimastigotes were fixed and incubated with mouse polyclonal antibodies raised against
recombinant TcCaNA2 or with rabbit polyclonal monospecific antibodies (immunopurified by affinity with the peptide 246–264) and then incubated
with the secondary antibody Alexa Fluor 488 goat anti-mouse IgG or the secondary antibody Alexa Fluor 568 goat anti-rabbit IgG, respectively.
Control refers to the reaction with the secondary antibodies only. B) Phosphatase activity in cytosolic extracts was determined in a population of
16107 epimastigotes in assay buffer with or without EGTA, Mn2+ and Ca2+ in accordance with the manufacturer’s instructions (Calcineurin Cellular
Activity Assay Kit, Colorimetric, Calbiochem). Data are represented as means 6 SD, the results are representative of three independent experiments.
doi:10.1371/journal.pntd.0002676.g006
A New Catalytic Subunit of Calcineurin in T. cruzi
PLOS Neglected Tropical Diseases | www.plosntds.org 10 January 2014 | Volume 8 | Issue 1 | e2676
whether they had been pretreated with sense or antisense
oligonucleotides and Endo-Porter or with Endo-Porter alone
(Figure S1), similar results were observed by Trypan blue exclusio´n.
Although all parasites exhibited high motility, only those treated
with antisense oligonucleotide and Endo-Porter had their capacity
to invade HeLa cells diminished (by about 75%). Untreated
parasites or those treated with sense oligonucleotides and Endo-
Porter or with Endo-Porter alone did not show a reduction in their
ability to invade these cells.
As epimastigote proliferation was reduced by CaN inhibitors
(Figure 1), we examined the contribution of TcCaNA2 in the
process using the antisense strategy as above. Epimastigotes in
exponential growth phase were treated or not with sense or
antisense oligonucleotides against TcCaNA2 for 72 h. Parasites
treated with antisense TcCaNA2 oligonucleotides showed a slight
decrease in their proliferative capacity (Figure 7B). The decrease in
TcCaNA2 expression in epimastigotes treated with antisense
oligonucleotides but not with their sense counterparts was
ascertained by immunoblotting using anti-TcCaNA2 antibodies,
55% according to densitometric analysis. As shown in Figure 7B
(lower panel), there was a marked decrease in TcCaNA2
expression when epimastigotes were treated with antisense
oligonucleotides. If TcCaNA2 played a critical role in epimastigote
replication, such a decrease would have had a greater effect on
proliferation.
Discussion
T. cruzi calcineurin (TcCaN) has been shown to play a role in
host cell invasion [15]. Recently, Kulkarni et al. [29] demonstrated
that parasites exposed to cyclophilin-trialysin exhibit enhanced
binding to and invasion of host cells, leading to higher infectivity
via calcineurin activation. In this study we found that TcCaN is
also implicated in the process of epimastigote replication.
Figure 7. Inhibitory effect of antisense TcCaNA2 oligonucleotides on T. cruzi cell invasion and proliferation. A) Upper panel: MT treated
for 24 h with the AS-ONs directed to TcCaNA2 and then incubated with HeLa cells for 3 h at 376C. After washes with PBS and staining with May-
Gru¨nwald Giemsa, the number of intracellular parasites in a total of 100 cells was counted. Values are the means 6 SD of at least three independent
experiments performed in triplicate. Statistical significance was determined by the Tukey test (p,0.05) ***p= 0.0008. The lower panel shows the
analysis of TcCaNA2 expression in the whole cell lysates detected by immunoblotting with a polyclonal antibody against TcCaNA2. In the lower panel,
equal protein loading was checked by immunoblotting with mouse anti-alpha tubulin. B) Upper panel: epimastigotes were cultured in 96-well
microplates in the presence or absence of AS-ONs. Cell counts were performed after 72 hours using a Neubauer hemocytometer. Values are the
means 6 SD of at least three independent experiments performed in triplicate. Statistical significance was determined by the Tukey test (p,0.05)
**p= 0.0038. The lower panel shows the analysis of TcCaNA2 expression in the whole cell lysates detected by immunoblotting with a polyclonal
antibody against TcCaNA2. In the lower panel equal protein loading was checked by immunoblotting with mouse anti-a tubulin.
doi:10.1371/journal.pntd.0002676.g007
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Furthermore, existing knowledge about Ca2+-dependent phospha-
tase TcCaN was further enhanced by characterization of the gene
coding for a new isoform of TcCaNA, the catalytic subunit A,
which exerts its activity through its association with the Ca2+-
binding regulatory subunit B (CaNB).
Unlike the CaNA homologous protein described by Moreno et
al. [14], which is predominantly localized in the parasite nucleus,
TcCaNA2 is cytoplasmic. TcCaNA2 contains two functional
domains: a catalytic domain homologous to the protein phospha-
tase 2A and the domain that interacts with TcCaNB, both
domains characteristic of previously reported CaNA homologs
[14,15]. The lack of a calmodulin-binding domain in TcCaNA2
indicates that its activity is independent of calmodulin. Compatible
with this was the finding that TcCaNA2 activity is enhanced by
Mn2+ rather than by Ca2+. The catalytic domain of PPP
(phosphoprotein phosphatase) has the phosphoesterase consensus
motif, with three conserved motifs in separate regions showing the
configuration DXH(X)n GDXXDR(X)m GNHD/E [30,31].
Although there are mutations in the catalytic site of TcCaNA2,
suggesting that it may behave as a pseudophosphatase [32],
arguments against this idea include the existence in TcCaNA2 of
histidine (H) in the GNHE domain, which acts as a proton donor
in the catalysis [33], in addition to the four amino acids involved in
metal coordination, of which only one is non-conserved. The
recombinant protein TcCaNA2 showed enzymatic activity using
p-NPP as substrate. Also, near the C-terminal portion of the
TcCaNA2 sequence there is the highly conserved SAPNY motif,
which is ‘‘conventional’’ in eukaryotic PPP, tyrosine (Y) being
implicated in the interaction with regulators and inhibitors [34–
37]. This is in contrast to what is found in other catalytic subunits
of CaN [for instance the a isoform of rat CaNA, in which a leucine
(L) residue is present in the SAPNYL motif making it more
susceptible to okadaic acid, a characteristic of phosphatases PP1
and PP2A] [38]. Together with the configuration of the invariant
PPP motifs in TcCnA-like, which adjusts to the configuration
-GDXHG-, -GDXVXRG-, -GNH- [14], the differences between
TcCnA-like and TcCaNA2 in the hydrophobic profiles of the
domain that interacts with TcCaNB suggest that these two
calcineurin-type protein phosphatases may play distinct functional
roles (data not shown). This is supported by their different
subcellular localization. Multiple sequence alignment of TcCaNA2
with catalytic subunits of calcineurin from other organisms,
revealed a 20 residues long stretch that is found only in
trypanosomatids, whose composition in T. cruzi is 243-
VSGGSGSDYYTPSAGPSYGS-262 (Figure 2A). The functional
relevance of this sequence is not known. Bioinformatics tools
associated the sequence with two motifs: one the NURR type
present in orphan nuclear receptors, and the other associated with
calpain-type cysteine proteases (data not shown).
Between one third and one half of all enzymes described to date
must associate with metals to perform their function [39]. In the
case of calcineurin, which belongs to the hydrolase class (EC
Number 3.1.3.16) and whose systematic name is phosphoprotein
phosphohydrolase, Fe3+ and Zn2+ have been described as
cofactors in its active site [40–42]. Our results showed that, under
the conditions assayed, the recombinant TcCaNA2 is activated by
Mn2+ and Ni2+, with no substantial activation by Mg2+ or Ca2+.
By sequentially removing the non-catalytic domains of CaN, such
as the calmodulin binding domain and autoinhibitory domain, Liu
et al. [24] observed increases in phosphatase activity, clearly
demonstrating that non-catalytic domains negatively regulate the
activity of the enzyme and act as intra-molecular inhibitors. This
sequential domain deletion favors CaN activation by Mn2+/Ni2+
but not by Mg2+, suggesting that enzyme activation by Mn2+/Ni2+
is mainly mediated via the catalytic domain [24]. Our finding that
TcCaNA2 lacks the calmodulin-binding domain and the auto-
inhibitory domain is consistent with its activation by Mn2+/Ni2+.
Assays using the recombinant TcCaNA2 showed that the enzyme
can function when dissociated from the regulatory subunit
TcCaNB. However, it should be borne in mind that inside the
parasite TcCaNA2 is bound to the Ca2+-binding regulatory
subunit TcCaNB (Figure 5) and that the enzyme is activated
during T. cruzi invasion of host cells, a process associated with an
increase in cytosolic Ca2+ concentration. Because of the presence
of a highly hydrophobic CaNB domain, which is located between
the catalytic and the calmodulin-binding domains, CaNA and
CaNB subunits form a heterodimer [43]. This interaction can only
be dissociated by strong denaturing agents such as urea at 6 M
[44]. We found that 6 M urea dissociates TcCaNA2 from
TcCaNB.
Calcineurin contributes in a variety of cellular signaling events
and activation processes [45]. In eukaryotic pathogens, it has been
associated in the regulation of specific steps of the cell cycle; in
intracellular Toxoplasma gondii, the loss of host cell potassium,
activates a phospholipase C that, in turn, causes an increase in
cytoplasmic [Ca2+] causing the parasite output from host cell, by
the activation of at least two signaling pathways: the protein kinase
and calcineurin [46]. Similarly, in T cruzi, entry into the host cell is
a process dependent [Ca2+], recent studies show that calcineurin,
specifically, the regulatory subunit CaNB is present in this parasite
(TcCaNB) and is involved in the process of invasion of target cells.
Treatment of parasites with antisense phosphorothioate oligonu-
cleotides directed to TcCaNB, which reduced the expression of
TcCaNB and affected TcCaN activity, resulted in ,50%
inhibition of HeLa cell entry by MT or TCT [15].
Kumar et al., [47], show that CsA inhibits the intraerythrocytic
replication of P. falciparum and that both, Cyp19A and Cyp19B,
are potent effectors of CsA-mediated inhibition of recombinant P.
falciparum CaNA in vitro. CsA-resistant parasites, isolated from
erythrocytic cultures, contained mutations in the CaNA and
CaNB subunits and in Cyp19A and Cyp19B. Using Geldanamy-
cin (GA), an inhibitor of plasmodial Hsp90 [48,49], they also show
that parasitic Hsp90 is associated with CaN, strongly suggesting
that Hsp90 regulates CaNA folding and hence regulates all cellular
events that require the phosphatase activity of calcineurin, so the
antimalarial activities of CsA and GA would be synergistic.
Potenza et al., [50], studied cDNA clones encoding cyclophilin
isoforms in epimastigotes of T. cruzi. These genes were also
detected in amastigotes and trypomastigotes. Four cyclosporin A-
binding proteins were isolated in epimastigote extracts, which were
identified by mass spectrometry as TcCyP19, TcCyP22, TcCyP28
and TcCyP40, these cyclophilins of T. cruzi would be of
importance to the mechanism of action of CsA. In the present
study, CsA and others calcineurin inhibitors, inhibit the invasion
and proliferation processes.
On the other hand, calcineurin is involved in the morphogenesis
and virulence of multiple pathogenic fungi: in Candida spp.,
calcineurin participates in antifungal drug resistance/tolerance,
survival in serum, and virulence [51–54]; in Paracoccidioides
brasiliensis, calcineurin plays a role in morphogenesis [55]; and in
Aspergillus fumigatus, calcineurin regulates morphogenesis and
thereby pathogenesis [56]. In addition, calcineurin is essential
for growth at elevated temperatures in the human fungal pathogen
Cryptococcus neoformans [57]. Studies conducted in the protozoan
parasite Leishmania major suggest that Ca2+ influx and activation of
calcineurin signaling is required for parasite differentiation and
adaptation to cellular stress encountered (elevated temperatures)
during infection of the mammalian host [58]. In this study, the
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disruption of calcineurin function, achieved by deletion of the gene
encoding the CnB subunit, had no effect on promastigote growth
at 27uC or the development of infectious metacyclic promastigotes
in stationary-phase cultures. However, disruption of calcineurin
function was associated with a marked increase in the sensitivity of
promastigotes to elevated temperature and perturbations in
membrane lipid composition. In our study, the temperature
changes do not affect the infective form (MT) in motility or
viability, both ATP-dependent processes [20], as demonstrated by
the parasite migration assay through gastric mucin layer. The
decrease of the invasive capacity of metacyclic forms, treated and
not treated with antisense oligonucleotides at 28uC, was not due to
diminished viability, because the parasites that were incubated at
37uC crossed through a polycarbonate transwell filter coated with
gastric mucin, demonstrating that are not affected by the
temperature stress. TcCaNA2 is expressed in all T. cruzi
developmental forms (Figure 3D). In metacyclic trypomastigotes,
the decrease in TcCaNA2 expression brought about by the use of
a TcCaNA2-targeted anti-sense strategy resulted in reduced
capacity to invade host cells. In previous studies, the anti-sense
approach directed to inhibit TcCaNB, the regulatory subunit with
EF-Hands Ca2+-linking motifs, rendered metacyclic forms as well
as tissue culture-derived trypomastigotes less infective toward
target cells [15]. It was also demonstrated that T. cruzi protein
dephosphorylation by TcCaN is in fact associated with a decrease
in parasite internalization assuming that treatment of metacyclic
forms with TcCaN inhibitor CsA, which diminishes the phos-
phorylation levels of serine/threonine residues of high-molecular-
weight proteins, inhibits host cell invasion [15]. An expansion of
the serine/threonine phosphatase family and a low proportion of
tyrosine phosphatases have been found in T. cruzi compared with
other eukaryotic genomes [32].
Another role of TcCaN is its involvement in parasite
multiplication. TcCaN inhibitor CsA affected epimastigote mul-
tiplication, confirming the data reported by Bu´a et al. [59]. CsA
probably binds to the cytosolic protein cyclophilin (CyP), forming
a complex that, through its association with the invariant
regulatory subunit TcCaNB, would inhibit TcCaN in a manner
similar to that of its mammalian counterpart [60]. Members of the
CyP family identified in T. cruzi, called peptidyl-prolyl cis/trans
isomerases, have their activity inhibited by CsA and its analogs
[59], and the affinity of CyP for CsA has been documented [61]. It
appears that the involvement of TcCaNA2 in epimastigote
proliferation is partial, as judged by the weak inhibitory effect
on epimastigote replication following treatment with antisense
oligonucleotides against TcCaNA2. It is possible therefore that the
major contribution to epimastigote replication comes from
TcCaNA bound to TcCaNB rather than from TcCaNA2/CaNB.
Assuming that T. cruzi expresses TcCaNA and TcCaNA2, both
of which can associate with TcCaNB, one interesting possibility is
that the two isoforms are engaged in distinct events during the
parasite life cycle. TcCaNA2/TcCaNB present in T. cruzi cytosol
would be predominantly activated in the infective trypomastigote
forms, leading to dephosphorylation of serine/threonine residues
of proteins implicated in cell invasion. In favor of this view is the
fact that a partial decrease in TcCaNA2 expression resulted in a
significant reduction in metacyclic trypomastigote internalization,
a short process involving signaling events in the cytosol, whereas
TcCaNA/TcCaNB may be activated in replicative epimastigote
forms to promote parasite proliferation, which implicates
transcription in the nucleus [62]. In addition to being inhibited
by CsA, epimastigote multiplication is inhibited by FK506 and
INCA-6, which are also CaN inhibitors. In a mechanism similar to
that associated with CsA, FK506 exerts its inhibitory effect by
forming a drug-immunophilin complex with CaN [63], whereas
the mechanism of action of INCA-6 is linked to blocking of the
substrate recognition site by a covalent union to CaN, inhibiting
dephosphorylation of nuclear factor of activated T cells (NFAT)
and interrupting the formation of the CaN-NFAT complex [64].
Similarly, kaempferol, binds directly to the catalytic site in CaNA
interacting with Leu 312 [65]. Our results showed no inhibition in
proliferation and cell invasion in parasites treated with kaempferol.
These findings are consistent with the absence of Leu 312 in
TcCaNA2 (Figures 1B and 2A).
The mechanism involving phosphorylation/dephosphorylation
events that play an important role in cell cycle progression, may
operate in T. cruzi epimastigotes. It is of note that T. cruzi TcCnA-
like protein has been detected predominantly in the nucleus of this
parasite [14]. TcCaNA2/CaNB and TcCaNA/CaNB, which
have distinct cellular localizations, may play a critical role at
different stages of T. cruzi development.
Many authors suggest calcineurin as a potential chemothera-
peutic target against pathogenic; fungi, helminths and protozoa
[46,47,66–70]. Our revision strongly supports that TcCaNA2 is a
good candidate for chemotherapeutic target given the differences
with its human counterpart. In fact, the T. cruzi calcineurin does
not possess the calmodulin binding domain and the autoinhibitory
domain which are present in the human enzyme. Besides this,
TcCaNA2 presents a 20 amino acids long stretch (243-
VSGGSGSDYYTPSAGPSYGS-262) in the catalytic domain that
is absent in the human calcineurin and is conserved in all
trypanosomatids with minimal differences. Also, comparative
sequence analysis shows only 44% of identity between human
calcineurin and TcCaNA. Taking into account that TcCaNA2
differs considerably in its primary structure from human CaNA
and that it may play a key role in host cell invasion by T. cruzi, it
should be considered a potential target for chemotherapeutic
intervention in Chagas disease.
Supporting Information
Figure S1 Effect of morpholino antisense oligonucleo-
tides on migration of T. cruzi metacyclic forms through
gastric mucin. Parasites, previously maintained for 16 h in PBS
at 28uC with morpholino sense or antisense oligos plus endoporter
or with endoporter alone, and the non treated controls were added
to the bottom of 24-well plates. Then polycarbonate transwell
filters coated with gastric mucin were placed onto parasite-
containing wells. After 1 h incubation at 37uC, samples from the
filter chamber were collected and the numbers of parasites
counted. Results were expressed as mean 6 standard deviations of
the three independent experiments performed in triplicate.
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